News for 'Lancet Study'

Lancet Flags HbA1c Unreliability In Indians

Lancet Flags HbA1c Unreliability In Indians

Rediff.com9 Feb 2026

The Lancet study revealed that the HbA1c test is erroneous in populations with anemia and other hemoglobin-related deficiencies in India.

Lancet Study finds Russian vaccine safe, effective

Lancet Study finds Russian vaccine safe, effective

Rediff.com4 Sep 2020

Results from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety profile detected over 42 days, and induce antibody responses in all participants within 21 days.

India's Stillbirth Rates: A Deep Dive into National Data Analysis

India's Stillbirth Rates: A Deep Dive into National Data Analysis

Rediff.com6 Apr 2026

A new analysis of national data reveals significant stillbirth rates in India and highlights the need for improved data collection and standardised reporting.

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Rediff.com20 Apr 2026

The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.

Covid patients' symptoms persist for a year: Lancet study

Covid patients' symptoms persist for a year: Lancet study

Rediff.com27 Aug 2021

The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with Covid-19.

One in eight recoverees suffer from long Covid, says comprehensive Lancet study

One in eight recoverees suffer from long Covid, says comprehensive Lancet study

Rediff.com5 Aug 2022

One in eight adults who are infected with SARS-CoV-2 experience long term symptoms due to Covid-19, according to one of the most comprehensive studies on the viral disease to date published in The Lancet journal on Friday.

1 in 4 experience mild side effects from Covishield: Lancet study

1 in 4 experience mild side effects from Covishield: Lancet study

Rediff.com28 Apr 2021

The researchers from King's College London in the United Kingdom also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days.

'India Is Staring At Dementia Epidemic'

'India Is Staring At Dementia Epidemic'

Rediff.com21 Nov 2025

'10 million Indians are currently living with dementia, and the number is expected to double by 2036.'

Experts question relying solely on HbA1c for diabetes test

Experts question relying solely on HbA1c for diabetes test

Rediff.com10 Feb 2026

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and blood disorders that can complicate the interpretation of values.

Why Walking Is The Real Flex

Why Walking Is The Real Flex

Rediff.com7 Nov 2025

We've all heard 'sitting is the new smoking' but the real question is: How do you undo it?

US foreign aid cuts can cause over 1.4 cr deaths by 2030: Study

US foreign aid cuts can cause over 1.4 cr deaths by 2030: Study

Rediff.com1 Jul 2025

The study said the fund cuts could reverse decades of progress and that for many low and middle-income countries, the resulting shock would be comparable in scale to a "global pandemic" or a "major armed conflict".

'India's biggest health crisis since Covid'

'India's biggest health crisis since Covid'

Rediff.com26 Dec 2025

Experts warn that air pollution in India is a major public health crisis, leading to a surge in undiagnosed airway diseases and cardiovascular issues. They urge for urgent action, early detection, and treatment.

3 Out Of 5 Cancer Patients Die In India

3 Out Of 5 Cancer Patients Die In India

Rediff.com3 Mar 2025

The mortality-to-incidence ratio for India was 64.47 per cent in 2022, the highest while comparing the top 10 countries with the highest number of cancer incidences.

How Women Voters Cemented Nitish Kumar's Political Fortress

How Women Voters Cemented Nitish Kumar's Political Fortress

Rediff.com6 Sep 2025

For nearly two decades, Nitish Kumar has cultivated women as a distinct constituency. 'To create a broader vote base, he thought it would be better to bring women to electoral politics.'

Walking 7,000 Steps Daily Can Reduce Risk Of...

Walking 7,000 Steps Daily Can Reduce Risk Of...

Rediff.com29 Jul 2025

Clocking in 7,000 steps a day could lower overall death risk by 47 per cent. And this is just one of the benefits.

'Alcohol Causes 7 Kinds Of Cancer'

'Alcohol Causes 7 Kinds Of Cancer'

Rediff.com11 Sep 2025

'After tobacco, the next most common cause for oral cancer is alcohol.'

Over 45? You Might Have Diabetes And Not Know It

Over 45? You Might Have Diabetes And Not Know It

Rediff.com8 Aug 2025

Nearly one in five older Indians are affected by diabetes with many remaining unaware that they have the disease.

New Covid variants not behind China outbreak, finds Lancet study

New Covid variants not behind China outbreak, finds Lancet study

Rediff.com10 Feb 2023

Two known Omicron sub-variants -- rather than any new variants -- have chiefly been responsible for the recent Covid-19 surge in China, according to a study of cases in Beijing published in The Lancet journal.

Now CBSE brings 'oil boards' to fight fat in schools

Now CBSE brings 'oil boards' to fight fat in schools

Rediff.com17 Jul 2025

The Central Board of Secondary Education (CBSE) has directed schools to establish 'oil boards' to educate students and staff about the dangers of consuming high-fat foods and oils, serving as daily reminders to promote healthier eating habits.

More boys diagnosed with cancer than girls in India: Lancet study

More boys diagnosed with cancer than girls in India: Lancet study

Rediff.com30 Nov 2022

More boys than girls with cancer in India are being diagnosed with the disease and the probable cause for this is gender bias in society, according to a study published in The Lancet Oncology.

Govt's obesity combat plan: Display oil and sugar in snacks

Govt's obesity combat plan: Display oil and sugar in snacks

Rediff.com14 Jul 2025

The Union health ministry is urging all ministries and departments to display 'oil and sugar boards' in common areas to raise awareness about hidden fats and sugars in everyday foods and promote healthier lifestyles.

Covid vaccine boosters not appropriate at this stage: Lancet study

Covid vaccine boosters not appropriate at this stage: Lancet study

Rediff.com13 Sep 2021

The results reported from the observational studies, on average, show that vaccination had 95 per cent efficacy against severe disease both from the Delta variant and from the Alpha variant, and over 80 per cent efficacy at protecting against any infection from these variants.

Why WHO should not have stopped HCQ clinical trials

Why WHO should not have stopped HCQ clinical trials

Rediff.com4 Jun 2020

'WHO has been under a lot of attack, so when they saw the Lancet study, they stopped the clinical trials of HCQ.' 'They should not have stopped the clinical trials.'

Covaxin 50% effective against symptomatic Covid: Lancet

Covaxin 50% effective against symptomatic Covid: Lancet

Rediff.com24 Nov 2021

Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.

Obesity: India's Next Pandemic?

Obesity: India's Next Pandemic?

Rediff.com24 Mar 2025

The number of Indian obese adults increased from 5.76 million in 1991 to 46.78 million in 2021; it is poised to reach 173.73 million by 2050.

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Rediff.com12 Nov 2021

The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.

What is Type 5 Diabetes?

What is Type 5 Diabetes?

Rediff.com16 May 2025

'Everyone with a low BMI will not get Type 5 diabetes.'

Covaxin has tolerable safety: Lancet

Covaxin has tolerable safety: Lancet

Rediff.com23 Jan 2021

The vaccine was well tolerated in all dose groups with no vaccine-related adverse events.

Bihar prohibition helps prevent 21L intimate partner violence, finds study

Bihar prohibition helps prevent 21L intimate partner violence, finds study

Rediff.com26 May 2024

The ban is also estimated to have prevented 18 lakh men in the state from becoming overweight or obese, it said.

Worrying! 13 of world's top 20 most polluted cities in India

Worrying! 13 of world's top 20 most polluted cities in India

Rediff.com11 Mar 2025

Four cities in neighbouring Pakistan and one in China are among the world's top 20 polluted cities.

Inhalers to the rescue as England players battle pollution in India

Inhalers to the rescue as England players battle pollution in India

Rediff.com2 Nov 2023

'Whether it was air quality or what, it was definitely an experience I've not had before.'

Half of India Faces Glucose Imbalance

Half of India Faces Glucose Imbalance

Rediff.com5 Dec 2024

'Obesity, especially central obesity and increased visceral fat due to physical inactivity, along with the consumption of high-calorie, high-fat, and high-sugar diets, are major contributing factors.'

Type 1 Diabetes On Rise In India

Type 1 Diabetes On Rise In India

Rediff.com3 Oct 2022

India on average lost 44.85 years of a lifetime due to Type 1 diabetes in 2021.

India among top 10 countries with highest Type 1 diabetes prevalence: Lancet

India among top 10 countries with highest Type 1 diabetes prevalence: Lancet

Rediff.com21 Sep 2022

This number is predicted to increase to 13.5-17.4 million people living with Type 1 diabetes by 2040, the researchers said.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

India saw 129,000 Alzheimer's and dementia deaths in 2019

India saw 129,000 Alzheimer's and dementia deaths in 2019

Rediff.com11 Oct 2022

Between 1990 and 2019, Alzheimer's-related deaths increased almost five times, data available on the Global Burden of Disease has found.

'I Don't Care How Much It Costs. Please Save My Mum'

'I Don't Care How Much It Costs. Please Save My Mum'

Rediff.com28 Mar 2025

'Doctors feel they have a duty to prolong a heartbeat at all costs.' 'And a son or a daughter feels, I can't let my mum die. I have to save her at all costs.' 'They think saving is just prolonging life. But the person suffers.'

Controversial study that claimed HCQ unsafe for COVID-19 retracted

Controversial study that claimed HCQ unsafe for COVID-19 retracted

Rediff.com5 Jun 2020

'Several concerns were raised with respect to the veracity of the data and analyses conducted by Surgisphere Corporation and its founder'

212 Million Indians Have Diabetes

212 Million Indians Have Diabetes

Rediff.com14 Nov 2024

Of these 212 million Indians, 133 million have untreated diabetes. Undiagnosed diabetes has been linked with complications such as diabetic retinopathy which can cause vision loss and blindness.

Financial crisis could send suicide, homicide rate

Financial crisis could send suicide, homicide rate

Rediff.com8 Jul 2009

Researchers at London School of Hygiene and Tropical Medicine and Oxford University headed the study to examine the possibility that health might suffer as a result of the market crashes. Lead author David Stuckler estimated that increased stress stemming from job losses could prompt a 2.4 per cent rise in suicide rates. Another 2.7 per cent rise in heart attack deaths could be expected, along with a 2.4 per cent increase in homicides rates.